Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Pfizer · Hormone Sensitive Prostate Cancer · Prostate Cancer
Phase 3
Active, not recruiting
1,068
2026-07
Industry sponsor intelligence
PfizerClinical Pipeline.
Lead-sponsor view of Pfizer's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 5
- Recruiting
- 0
- Active
- 1
- Completed
- 3
- Results posted
- 4
- Avg enrollment
- 751
Pipeline overview
Programs by phase and activity.
Velocity
Pfizer trials by start year
Study start year · indexed snapshot
Development
Trials by phase
4phase labels
Early Phase 10
Phase 11
Phase 21
Phase 31
Phase 41
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Calcitonin → | 2 | 1 | 0 | 0 | 1 | 0 |
| Leuprolide → | 1 | 0 | 0 | 1 | 0 | 1 |
| Nesiritide → | 1 | 0 | 1 | 0 | 0 | 0 |
| Degarelix → | 1 | 0 | 0 | 0 | 0 | 0 |
| Triptorelin → | 1 | 0 | 0 | 0 | 0 | 0 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults
Pfizer · Healthy Volunteer
Phase 1
Completed
64
2026-05
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer · Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Metastatic Castration Resistant Prostate Cancer (mCRPC)
Not applicable
Completed
1,083
2026-01
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
Pfizer · Migraine
Phase 4
Completed
1,415
2025-12
Search sponsor records
All Pfizer studies.
This page groups studies where Pfizer is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
5 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT02319837Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)Jul 9, 2026NCT07261371A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy AdultsMay 4, 2026NCT05492500A Study of Ponsegromab in People With Heart FailureMar 18, 2026NCT05701007Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandJan 29, 2026NCT05217927Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing RegimensDec 16, 2025